Mechanism of Cholera Toxin Action: ADP-Ribosylation Factors as Stimulators of Cholera Toxin-Catalyzed ADP-Ribosylation and Effectors in Intracellular Vesicular Trafficking Events

2000 ◽  
pp. 133-165 ◽  
Author(s):  
W. A. Patton ◽  
N. Vitale ◽  
J. Moss ◽  
M. Vaughan



1982 ◽  
Vol 257 (1) ◽  
pp. 20-23 ◽  
Author(s):  
L.S. Schleifer ◽  
R.A. Kahn ◽  
E. Hanski ◽  
J.K. Northup ◽  
P.C. Sternweis ◽  
...  




1988 ◽  
Vol 156 (3) ◽  
pp. 1160-1165 ◽  
Author(s):  
Naoka Komori ◽  
Maureen A. Rider ◽  
Dolores J. Takemoto ◽  
Hitoshi Shichi ◽  
Hiroyuki Matsumoto




Biochemistry ◽  
1993 ◽  
Vol 32 (2) ◽  
pp. 561-566 ◽  
Author(s):  
Toshihiko Murayama ◽  
Su Chen Tsai ◽  
Ronald Adamik ◽  
Joel Moss ◽  
Martha Vaughan


1995 ◽  
Vol 306 (3) ◽  
pp. 765-769 ◽  
Author(s):  
R Levistre ◽  
M Berguerand ◽  
G Bereziat ◽  
J Masliah

Pretreatment of alveolar macrophages with cholera toxin inhibits the release of arachidonic acid induced by the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine. The results presented here show that cholera toxin might exert its inhibitory effect through the phosphorylation of Gi alpha by protein kinase A (PKA). (1) Gi-proteins from cells pretreated with cholera toxin showed parallel increases in their sensitivity to ADP-ribosylation by toxins in vitro and in Gi alpha phosphorylation. By contrast, the Gi alpha concentration was unchanged. (2) Cholera toxin pretreatment also decreased the functional activity of Gi, as assessed by the inhibition (80%) of agonist-induced binding of guanosine-5′-[gamma-thio]triphosphate (GTP[gamma S]). (3) These effects of cholera toxin were blocked by a specific PKA inhibitor, N-(2-[methyl-amino]ethyl)-3-isoquinolinesulphonamide dihydrochloride (H8) and mimicked by a cyclic AMP (cAMP) analogue and a phosphatase inhibitor. (4) Gi alpha was also phosphorylated in vitro by the catalytic subunit of PKA. In contrast with other cell systems, the stimulation of protein kinase C seems to have no effect on the sensitivity of Gi to ADP-ribosylation or on its phosphorylation. Therefore, the phosphorylation of Gi-proteins by PKA seems to be the actual target of the negative control of arachidonic acid release via the cAMP-mediated pathway.



Sign in / Sign up

Export Citation Format

Share Document